Vimarsana
Biggest News Aggregation in the World

Page 3 - Thomas Equels News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Equels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Equels Today - Breaking & Trending Today

AIM ImmunoTech Inc reveals positive pilot study data from EAP evaluating Ampligen for treatment of Long COVID - Vimarsana News

AIM ImmunoTech Inc reveals positive pilot study data from EAP evaluating Ampligen for treatment of Long COVID

AIM ImmunoTech Inc (NYSE:AIM) has announced what it calls positive preliminary pilot study data from its ongoing Expanded Access Program (EAP) evaluating...

NA Proactive news snapshot: Virtual Investor Conferences, Water Tower Research, Todos Medical Ltd, Unigold Inc, Belmont Resources Inc, Numinus Wellness Inc UPDATE ... - Vimarsana News

NA Proactive news snapshot: Virtual Investor Conferences, Water Tower Research, Todos Medical Ltd, Unigold Inc, Belmont Resources Inc, Numinus Wellness Inc UPDATE ...

Virtual Investor Conferences (VIC), the leading proprietary investor conference series, in partnership with Zacks Small-Cap Research, today announced the...

AIM ImmunoTech Inc signs lease deal for new state-of-the-art product development and testing facility in New Jersey - Vimarsana News

AIM ImmunoTech Inc signs lease deal for new state-of-the-art product development and testing facility in New Jersey

AIM ImmunoTech Inc (NYSE:AIM) announced that it has entered into a lease agreement with the New Jersey Economic Development Authority for a 5,210 square...

NA Proactive news snapshot: Cypress Development Corp, CO2 GRO Inc, My Size Inc, Arizona Silver Exploration Inc, BioPorto A/S UPDATE ... - Vimarsana News

NA Proactive news snapshot: Cypress Development Corp, CO2 GRO Inc, My Size Inc, Arizona Silver Exploration Inc, BioPorto A/S UPDATE ...

Virtual Investor Conferences (VIC), the leading proprietary investor conference series, in partnership with Zacks Small-Cap Research, today announced the...

AIM ImmunoTech Provides Summary of Ampligen® Data - Vimarsana News

AIM ImmunoTech Provides Summary of Ampligen® Data

Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors ...